Cargando…

Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Dissecting New Mechanism of Action Through In Vitro and In Vivo Analyses

Detalles Bibliográficos
Autores principales:	López-Urrutia, Eduardo, Padilla-Benavides, Teresita, Pérez-Plasencia, Carlos, Campos-Parra, Alma D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521020/ https://www.ncbi.nlm.nih.gov/pubmed/34671566 http://dx.doi.org/10.3389/fonc.2021.773429

Ejemplares similares

Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Clinical Insights to Improve Oncologic Therapies
por: Pérez-Plasencia, Carlos, et al.
Publicado: (2021)

Editorial: Novel approaches to study metals in molecular biology
por: Padilla-Benavides, Teresita, et al.
Publicado: (2023)

Crosstalk Between Long Non-coding RNAs, Micro-RNAs and mRNAs: Deciphering Molecular Mechanisms of Master Regulators in Cancer
por: López-Urrutia, Eduardo, et al.
Publicado: (2019)

Interplay Between Autophagy and Wnt/β-Catenin Signaling in Cancer: Therapeutic Potential Through Drug Repositioning
por: Pérez-Plasencia, Carlos, et al.
Publicado: (2020)

Alternative splicing regulation in tumor necrosis factor-mediated inflammation
por: López-Urrutia, Eduardo, et al.
Publicado: (2017)

Pathogenic variant profile in DNA damage response genes correlates with metastatic breast cancer progression-free survival in a Mexican-mestizo population
por: Vázquez-Romo, Rafael, et al.
Publicado: (2023)

Editorial: Tumor Cell Metabolism and Autophagy as Therapeutic Targets
por: Jacobo-Herrera, Nadia, et al.
Publicado: (2020)

Editorial: in vitro and in vivo non-clinical models of kidney cancers
por: Dormoy, Valérian, et al.
Publicado: (2022)

Editorial: Altered Expression of Proteins in Cancer: Function and Potential Therapeutic Targets
por: Pessoa, João, et al.
Publicado: (2022)

Editorial: Biological aspects of targeted drug discovery: Development of novel targets and/or chemotherapies, and drug repurposing
por: Kalra, Rajkumar Singh, et al.
Publicado: (2022)

Non-Coding RNAs Associated With Radioresistance in Triple-Negative Breast Cancer
por: Aranza-Martínez, Alberto, et al.
Publicado: (2021)

Inhibition of Wnt-β-Catenin Signaling by ICRT14 Drug Depends of Post-Transcriptional Regulation by HOTAIR in Human Cervical Cancer HeLa Cells
por: Trujano-Camacho, Samuel, et al.
Publicado: (2021)

Editorial: In vivo and in vitro models for research in pathology
por: Tan, Songwen, et al.
Publicado: (2023)

Editorial: Altered expression of proteins in cancer: function and potential therapeutic targets, volume II
por: Pessoa, João, et al.
Publicado: (2023)

Combination of Metformin, Sodium Oxamate and Doxorubicin Induces Apoptosis and Autophagy in Colorectal Cancer Cells via Downregulation HIF-1α
por: Coronel-Hernández, Jossimar, et al.
Publicado: (2021)

Micro-RNAs as Potential Predictors of Response to Breast Cancer Systemic Therapy: Future Clinical Implications
por: Campos-Parra, Alma D., et al.
Publicado: (2017)

Dissecting the Mechanism of Action of Spiperone—A Candidate for Drug Repurposing for Colorectal Cancer
por: Antona, Annamaria, et al.
Publicado: (2022)

Gene Promoter-Methylation Signature as Biomarker to Predict Cisplatin-Radiotherapy Sensitivity in Locally Advanced Cervical Cancer
por: Contreras-Romero, Carlos, et al.
Publicado: (2022)

Drug Repurposing by Tumor Tissue Editing
por: Lüke, Florian, et al.
Publicado: (2022)

Validity of a questionnaire on self-efficacy for Pap test adherence screening
por: Urrutia, María-Teresa, et al.
Publicado: (2022)

Editorial: Molecular pathology and computational image analyses in gynecologic malignancies
por: Malapelle, Umberto, et al.
Publicado: (2022)

Editorial: Drug Repurposing
por: Pantziarka, Pan, et al.
Publicado: (2019)

Repurposing of Drug Candidates for Treatment of Skin Cancer
por: Cortés, Hernán, et al.
Publicado: (2021)

Mifepristone Repurposing in Treatment of High-Grade Gliomas
por: Llaguno-Munive, Monserrat, et al.
Publicado: (2021)

Repurposing Infectious Diseases Vaccines Against Cancer
por: Vandeborne, Liese, et al.
Publicado: (2021)

Prediction and Identification of GPCRs Targeting for Drug Repurposing in Osteosarcoma
por: Tan, Manli, et al.
Publicado: (2022)

Emerging target discovery and drug repurposing opportunities in chordoma
por: Freed, Daniel M., et al.
Publicado: (2022)

Long Non-Coding RNAs as New Master Regulators of Resistance to Systemic Treatments in Breast Cancer
por: Campos-Parra, Alma D., et al.
Publicado: (2018)

Editorial: Complications of Neck Dissection for Thyroid Cancer
por: Shaha, Ashok R.
Publicado: (2007)

Rationally Repurposing Ruxolitinib (Jakafi(®)) as a Solid Tumor Therapeutic
por: Tavallai, Mehrad, et al.
Publicado: (2016)

Improving the Therapeutic Efficacy of Sorafenib for Hepatocellular Carcinoma by Repurposing Disulfiram
por: Zhang, Gong, et al.
Publicado: (2022)

Editorial: Multiplexed image analysis for translational research project applications
por: Capelozzi, Vera Luiza, et al.
Publicado: (2022)

LncRNA MALAT1 Promotes Tumor Angiogenesis by Regulating MicroRNA-150-5p/VEGFA Signaling in Osteosarcoma: In-Vitro and In-Vivo Analyses
por: Vimalraj, Selvaraj, et al.
Publicado: (2021)

Epidrug Repurposing: Discovering New Faces of Old Acquaintances in Cancer Therapy
por: Montalvo-Casimiro, Michel, et al.
Publicado: (2020)

Pathway-Based Drug-Repurposing Schemes in Cancer: The Role of Translational Bioinformatics
por: Hernández-Lemus, Enrique, et al.
Publicado: (2021)

Editorial: Cancer and nutrients: new chemicals, signals, and biomarker-based therapy
por: Qin, Xian-Yang, et al.
Publicado: (2023)

Repurposing of anticancer drugs: in vitro and in vivo activities against Schistosoma mansoni
por: Cowan, Noemi, et al.
Publicado: (2015)

Developments in Blood-Brain Barrier Penetrance and Drug Repurposing for Improved Treatment of Glioblastoma
por: Harder, Bryan G., et al.
Publicado: (2018)

Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis
por: Zhang, Hongjun, et al.
Publicado: (2022)

Repurposing live attenuated trivalent MMR vaccine as cost-effective cancer immunotherapy
por: Zhang, Yuguo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_quee7d60o70562cvg9djq9h7m2